POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
High Impact

Vermont Bill H.136 requires health insurers and Medicaid to cover biomarker testing starting in 2026

Original title: An act relating to health insurance coverage for biomarker testing

Last action · February 4, 2025: Read first time and referred to the Committee on Health CareSponsors: Kate McCann and 21 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Vermont House Bill 136 requires private health insurance plans and Medicaid to cover testing for the diagnosis, treatment, and ongoing monitoring of diseases starting January 1, 2026. The coverage must be supported by medical and scientific evidence such as FDA approvals or clinical practice guidelines, and must be delivered in a manner that limits care disruptions like multiple biopsies.

Why it matters

Patients requiring specialized genetic or molecular testing for conditions like cancer will have coverage mandated across health plans and Medicaid, shifting diagnostic costs to insurers while altering clinical testing protocols.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

health insurers

Health insurers must update their health insurance plans to provide coverage for biomarker testing meeting specific scientific and medical evidence standards.

Directly affected

Medicaid beneficiaries

Medicaid beneficiaries gain eligibility for covered biomarker testing services for disease diagnosis, treatment, and monitoring.

Directly affected

Agency of Human Services

The Agency of Human Services must implement Medicaid coverage for biomarker testing and request any necessary state plan amendments from CMS.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What types of tests are covered under this bill?
The bill covers testing including , multiplex panel tests, protein expression analysis, and whole exome, whole genome, and whole transcriptome sequencing when supported by medical and scientific evidence.
When will health insurance plans be required to provide this coverage?
Private health insurance plans must provide coverage starting January 1, 2026, as plans are issued, reissued, or renewed, and no later than January 1, 2027.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

1 action
  1. Feb 4, 2025HouseIntroduced
    Read first time and referred to the Committee on Health Care

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Agency of Human Services, U.S. Food and Drug Administration, Centers for Medicare and Medicaid Services and 1 more
OrganizationAgency of Human Services“State agency required to provide Medicaid coverage and request state plan amendm”Map →
OrganizationU.S. Food and Drug Administration“Federal agency approving or clearing tests and drugs”Map →
OrganizationCenters for Medicare and Medicaid Services“Federal agency handling national coverage determinations and state plan amendmen”Map →
OrganizationGeneral Assembly of the State of Vermont“Legislative body enacting the bill”Map →

Sources

Open source document

legislature.vermont.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy25
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record